Literature DB >> 10376441

Helicobacter pylori associated gastric pathology in patients with type II diabetes mellitus and its relationship with gastric emptying: the Ankara study.

N Güvener1, Y Akcan, I Paksoy, A R Soylu, M Aydin, S Arslan, O Gedik.   

Abstract

Helicobacter pylori (HP) is the most common cause of nonerosive nonspecific gastritis. Gastric and duadenal ulcer both are found to be associated with HP infection. Another consequence of HP infection is that it may progress to chronic atrophic gastritis which is a well recognized risk factor for adenocarcinoma of the stomach. So by extension, HP infection can be accepted as a risk factor for gastric cancer. From this aspect, identification of risk groups is increasingly important. It is well-known that patients with diabetes mellitus are more prone to infection. Besides this, presence of gastroparesis diabeticorum may lead to bacterial overgrowth in the upper gastrointestinal (GI) tract. The present crossectional study was planned to study the presence of HP infection in diabetic patients with alterations in upper GI motility and to compare the results with healthy control group. Group I consisted of 51 patients with type II diabetes mellitus (as defined by National Data Group criteria) without any dyspeptic symptoms. Twenty-five age-matched healthy people served as a control in group II. Radionuclide-labelled solid meals were used to calculate gastric emptying time (GET). According to the results, patients in group I were divided into two groups. Patients with prolonged GET were grouped as group IA, while group IB consisted of patients with normal or shortened GET. Presence of HP gastritis is determined by histopathologic examination of endoscopic biopsy specimen. The results showed that the prevalence of HP gastritis in group I and II were 80.4% and 56% respectively and the difference was significant statistically (p: 0.03). In group IA, the prevalence of HP infection was estimated to be 88.2%, while in group IB it was 76.5% but the difference was not significant (p: 0.31). We have not found any correlation between HbA1c levels and the presence of HP infection in both group IA and IB (p values 0.26 and 0.15 respectively). We conclude that the prevalence of HP gastritis is higher in asymptomatic diabetic patients compared with healthy people. But there is no association between the alterations in GET and the presence of HP gastritis as indicated by our results. So prolonged GET may not be regarded as a specific pathogenic mechanism or a cause of HP infection in NIDDM patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10376441     DOI: 10.1055/s-0029-1212093

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  10 in total

1.  A patient with impaired gastric motility.

Authors:  P A Paine; W Rees; C Babbs; J L Shaffer; G Armstrong; H Burnett; Q Aziz
Journal:  Gut       Date:  2007-11       Impact factor: 23.059

2.  Association between gastric Helicobacter pylori colonization and glycated hemoglobin levels.

Authors:  Yu Chen; Martin J Blaser
Journal:  J Infect Dis       Date:  2012-03-13       Impact factor: 5.226

3.  Helicobacter pylori infection is not associated with delayed gastric emptying or upper gastrointestinal symptoms in diabetes mellitus.

Authors:  Karen L Jones; Judith M Wishart; Melanie Berry; Antonietta Russo; Harry Hua-Xiang Xia; Nicholas J Talley; Michael Horowitz
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

4.  Type 2 diabetes mellitus affects eradication rate of Helicobacter pylori.

Authors:  Mehmet Sargýn; Oya Uygur-Bayramicli; Haluk Sargýn; Ekrem Orbay; Dilek Yavuzer; Ali Yayla
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

5.  Incidence of reflux esophagitis and H pylori infection in diabetic patients.

Authors:  Ken Ariizumi; Tomoyuki Koike; Shuichi Ohara; Yoshifumi Inomata; Yasuhiko Abe; Katsunori Iijima; Akira Imatani; Tomoyoshi Oka; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2008-05-28       Impact factor: 5.742

6.  Helicobacter pylori prevalence in diabetes mellitus patients with dyspeptic symptoms and its relationship to glycemic control and late complications.

Authors:  Mehmet Demir; Huseyin Savas Gokturk; Nevin Akcaer Ozturk; Mustafa Kulaksizoglu; Ender Serin; Ugur Yilmaz
Journal:  Dig Dis Sci       Date:  2008-03-05       Impact factor: 3.199

7.  United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis.

Authors:  Jolien Schol; Lucas Wauters; Ram Dickman; Vasile Drug; Agata Mulak; Jordi Serra; Paul Enck; Jan Tack
Journal:  United European Gastroenterol J       Date:  2021-04       Impact factor: 4.623

8.  Vomiting and dysphagia predict delayed gastric emptying in diabetic and nondiabetic subjects.

Authors:  Doron Boltin; Ibrahim Zvidi; Adam Steinmetz; Hanna Bernstine; David Groshar; Yuval Nardi; Mona Boaz; Yaron Niv; Ram Dickman
Journal:  J Diabetes Res       Date:  2014-05-11       Impact factor: 4.011

9.  The effect of the treatment of Helicobacter pylori infection on the glycemic control in type 2 diabetes mellitus.

Authors:  Homayon Zojaji; Elnaz Ataei; Somayeh Jahani Sherafat; Mehdi Ghobakhlou; Seyed Reza Fatemi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013

Review 10.  Helicobacter pylori Infection Is Associated with Type 2 Diabetes, Not Type 1 Diabetes: An Updated Meta-Analysis.

Authors:  Jun-Zhen Li; Jie-Yao Li; Ting-Feng Wu; Ji-Hao Xu; Can-Ze Huang; Di Cheng; Qi-Kui Chen; Tao Yu
Journal:  Gastroenterol Res Pract       Date:  2017-08-13       Impact factor: 2.260

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.